
Federal regulators plan to authorize an additional dose for seniors and immunocompromised people in the coming weeks, ahead of the introduction of a newly formulated booster later in the year. By Noah Weiland and Sharon LaFraniere from NYT U.S. https://ift.tt/hA53Ve4
Comments
Post a Comment